8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 2, 2005

MEDTOX SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)

Delaware	1-11394	95-3863205
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification No.)

402 West County Road D, St. Paul, Minnesota	55112
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (651) 636-7466

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01.    Other Events

On August 2, 2005, MEDTOX Scientific, Inc. announced the number of warrants that were converted to common stock, as described in the press release attached as Exhibit 99.1.

2

Item 9.01.    Financial Statements and Exhibits.

(c) Exhibits.

        The following exhibit is filed as part of this report:

Exhibit No.	Description
10.1	MEDTOX Scientific, Inc. Press Release, dated August 2, 2005.

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MEDTOX Scientific, Inc.
Date:   August 2, 2005	By:          /s/ Richard J. Braun
	Name:     Richard J. Braun
	Title:       Chief Executive Officer

4

INDEX TO EXHIBITS

Exhibit No.	Description
10.1	MEDTOX Scientific, Inc. Press Release, dated August 2, 2005.

5

EX-99

Exhibit 99.1

MEDTOX Scientific, Inc.
402 West County Road D
St. Paul, MN 55112
Contact: Joseph Jennings (877) 715-7236

FOR IMMEDIATE RELEASE

MEDTOX SCIENTIFIC, INC. ANNOUNCES CONVERSION OF WARRANTS

ST.  PAUL, August 2, 2005 – MEDTOX Scientific, Inc. (AMEX-TOX), announced today that out of a total of 1,120,439 Warrants for purchase of Common Stock of MEDTOX Scientific, Inc., 424,034 were exercised and converted to common stock at $6.75 per share. 497,581 of these warrants expired without being exercised on July 31, 2005. The Company received $2,862,229.50 in proceeds from the common stock warrant conversion. The remaining 198,824 warrants will expire on August 31, 2005. The exercise price of those warrants is $6.75 per share.

The Company also announced that Charlotte Sebastian has joined MEDTOX as Director of Human Resources. Charlotte has over twenty years experience as a human resources professional with extensive exposure to the medical diagnostics industry. Most recently she was Human Resources Manager for the Minnesota Operations of Mentor Corporation and previously was with Medtronic, Inc. Her education and professional credentials include a B.A., M.A. and certification as a Senior Professional in Human Resources (SPHR). As part of her negotiated employment arrangement and as an inducement to accept this position, she has been granted 5,000 restricted shares that vest at the end of four years.

MEDTOX Scientific, Inc., headquartered in St. Paul, Minn., is a provider of high quality specialized laboratory testing services and on-site/point-of-collection (POC) devices. The company also supports customers with complete logistics, data and program management services. MEDTOX is a leader in providing esoteric laboratory testing services to hospitals and laboratories nationwide. This includes both central laboratory and bio-analytical testing for pharmaceutical clinical trials. MEDTOX develops and manufactures diagnostic devices for quick and economical on-site/point-of-collection analysis for drugs-of-abuse, therapeutic drugs and biological and agricultural toxins and provides employment drug screening and occupational health testing. For more information see www.medtox.com.